News
With the exception of "Editorial use only" photos (which can only be used in editorial projects and can't be modified), the possibilities are limitless. Learn more about royalty-free images or view ...
Choose from Antibody Molecular Structure stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Plans and pricing ...
The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for sibeprenlimab for the treatment of immunoglobulin A nephropathy (IgAN ...
Eric Dane, appearing on today’s Good Morning America, said in a taped interview with Diane Sawyer that due to ALS he no ...
The immunoglobulin medication currently in use in Sri Lanka meets proper quality standards, confirmed National Medicines Regulatory Authority (NMRA) Chairman Dr. Ananda Wijewickrama in a statement ...
Targeted hypermutation of immunoglobulin variable region genes occurs in B cells during an immune response1, and gives rise to families of related mutant antibodies which are then selected for ...
In-force illustrations can be obtained on a life insurance policy that is in force, or active. In other words, you can’t get one for a policy that has lapsed or is no longer in force.
Colombo, June 3 (Daily Mirror) - The Attorney General has informed the Supreme Court that former Health Minister Keheliya Rambukwella and several others accused in the controversial importation of ...
Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, United States ...
By binding and inhibiting APRIL, sibeprenlimab may help reduce the amount of immunoglobulin A (IgA) and Gd-IgA1 levels. Lower levels of Gd-IgA1 provide less substrate for immune complex formation ...
Cobra venoms are enriched with toxins of low molecular mass, known as three-finger toxins (Panel A). Some of these are neurotoxins, which bind with high affinity to the nicotinic cholinergic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results